Remifentanil And Local Anesthesia Compared With Local Anesthesia For The Insertion Of Central Venous Catheters
- Registration Number
- NCT02206022
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
At present, there is no reference protocol for Central Venous Catheter (CVC) insertion assuring analgesia, anxiolysis and safety. Medical teams use various levels of analgesia and anesthesia to realize this gesture, from single local anesthesia to general anesthesia. Remifentanil has been shown to decrease pain scores for insertion and removal of long-term central venous access. Remifentanil is also often employed for pediatric or labor analgesia for short acts as procedural sedation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
- more than 18 years old
- eligible for CVC insertion
Exclusion Criteria
- pregnancy
- patients who can't give their consent
- contra-indications to remifentanil infusion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Remifentanil Remifentanil Patients who undergone a Central Venous Catheter (CVC) insertion under remifentanil infusion Placebo Placebo Patients who undergone a Central Venous Catheter (CVC) insertion under placebo infusion
- Primary Outcome Measures
Name Time Method Maximal pain score on numeric rating scale (NRS) will be assessed after the insertion up to 60 minutes
- Secondary Outcome Measures
Name Time Method Evaluation of patient's anxiety by the Face Anxiety Scale up to 60 minutes Patient and physician's satisfaction by a 10-points numeric rating scale up to 60 minutes Number of adverse events up to 60 minutes Number of realized punctions up to 60 minutes
Trial Locations
- Locations (1)
University Hospital of Toulouse
🇫🇷Toulouse, France